Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer
- Citation:
- J Natl Cancer Inst vol 102 (13) 942-949
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, CA33601, CA77597, CA04457, U10 CA077658, CA02599, CA77406, CA47577, CA35113, CA32291, CA41287, U10 CA045808, CA03927, U10 CA045389, CA60138, CA45389, CA37447, U10 CA077597, CA45808, CA12046, U10 CA045418, U10 CA041287, U10 CA035113, CA21060, CA47642, CA45418, CA77658, CA12449, U10 CA047642, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Judy E. Garber Susan Halabi Sara M. Tolaney Ellen Kaplan Laura Archer James N. Atkins Stephen Edge Charles L. Shapiro Lynn Dressler Electra M. Paskett Gretchen Kimmick James Orcutt Anthony Scalzo Eric Winer Ellis Levine Nasir Shahab Nancy Berliner
- Networks:
- Study
- CALGB-9872
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- Articles